Gregory Cheng

733 total citations
28 papers, 602 citations indexed

About

Gregory Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gregory Cheng has authored 28 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Gregory Cheng's work include Beetle Biology and Toxicology Studies (4 papers), Antimicrobial Peptides and Activities (4 papers) and Natural product bioactivities and synthesis (3 papers). Gregory Cheng is often cited by papers focused on Beetle Biology and Toxicology Studies (4 papers), Antimicrobial Peptides and Activities (4 papers) and Natural product bioactivities and synthesis (3 papers). Gregory Cheng collaborates with scholars based in Hong Kong, China and Italy. Gregory Cheng's co-authors include Raymond Wong, Stanton Kok, Johnny Tang, Roberto Gambari, Chung Chui, Kim Hung Lam, Fung Lau, Chung-Hin Chui, Paul B.S. Lai and A.S.C. Chan and has published in prestigious journals such as Cancer Research, Carbohydrate Polymers and European Journal of Medicinal Chemistry.

In The Last Decade

Gregory Cheng

28 papers receiving 581 citations

Peers

Gregory Cheng
Najla Altwaijry Saudi Arabia
Jun Chang China
Estelle Henry Luxembourg
Sohyun Kim South Korea
Gregory Cheng
Citations per year, relative to Gregory Cheng Gregory Cheng (= 1×) peers Debabrat Baishya

Countries citing papers authored by Gregory Cheng

Since Specialization
Citations

This map shows the geographic impact of Gregory Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cheng more than expected).

Fields of papers citing papers by Gregory Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cheng. The network helps show where Gregory Cheng may publish in the future.

Co-authorship network of co-authors of Gregory Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Cheng. A scholar is included among the top collaborators of Gregory Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Cheng. Gregory Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, P.-L., Stanton Kok, Raymond Wong, et al.. (2012). A novel green gelatin–agar microencapsulation system with P. urinaria as an improved anti-A. niger model. Carbohydrate Polymers. 92(1). 877–880. 19 indexed citations
2.
Lam, P.-L., KK Lee, Stanton Kok, et al.. (2012). Development of formaldehyde-free agar/gelatin microcapsules containing berberine HCl and gallic acid and their topical and oral applications. Soft Matter. 8(18). 5027–5027. 71 indexed citations
3.
Yuen, Marcus Chun‐Wah, P.-L. Lam, Roberto Gambari, et al.. (2010). Synthesis, characterization and preliminary analysis of in vivo biological activity of chitosan/celecoxib microcapsules. Bioorganic & Medicinal Chemistry Letters. 20(14). 4147–4151. 20 indexed citations
4.
Hau, Desmond Kwok-Po, Guo‐Yuan Zhu, Alexander Kai‐Man Leung, et al.. (2010). In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma. Phytomedicine. 18(1). 11–15. 47 indexed citations
5.
Hau, Desmond Kwok-Po, Raymond Wong, Gregory Cheng, et al.. (2010). Novel Use of Silymarin as Delayed Therapy for Acetaminophen-Induced Acute Hepatic Injury. PubMed. 17(4). 209–213. 12 indexed citations
6.
Lam, Kim Hung, Chung-Hin Chui, Roberto Gambari, et al.. (2010). The preparation of bi-functional organophosphine oxides as potential antitumor agents. European Journal of Medicinal Chemistry. 45(11). 5527–5530. 15 indexed citations
7.
Chui, Chung-Hin, Raymond Wong, Roberto Gambari, et al.. (2009). Antitumor activity of diethynylfluorene derivatives of gold(I). Bioorganic & Medicinal Chemistry. 17(23). 7872–7877. 56 indexed citations
8.
Lu, Guo‐Liang, Cheuk‐Lam Ho, Qiwei Wang, et al.. (2008). Synthesis and Characterization of Some Metal Complexes of 4,5-Diazafluoren-9-one and their Biological Effects on Human Carcinoma Cells. Australian Journal of Chemistry. 61(12). 975–980. 8 indexed citations
9.
Chui, Chung, Roberto Gambari, Fung Lau, et al.. (2006). In vitro anti-cancer activity of a novel microbial fermentation product on human carcinomas. International Journal of Molecular Medicine. 17(4). 675–9. 1 indexed citations
10.
Kok, Stanton, Chung Chui, Kim Hung Lam, et al.. (2006). Mechanistic insight into a novel synthetic cantharidin analogue in a leukaemia model. International Journal of Molecular Medicine. 18(2). 375–9. 13 indexed citations
11.
Kok, Stanton, Chung Chui, Kim Hung Lam, et al.. (2006). Apoptogenic activity of a synthetic cantharimide in leukaemia: Implication on its structural activity relationship. International Journal of Molecular Medicine. 18(6). 1217–21. 12 indexed citations
12.
Chui, Chung, Raymond Wong, Gregory Cheng, et al.. (2006). Antiproliferative ability of a combination regimen of crocodile egg extract, wild radix ginseng and natural Ganoderma lucidum on acute myelogenous leukemia. Oncology Reports. 16(6). 1313–6. 10 indexed citations
13.
Kok, Stanton, Chung Chui, Kim Hung Lam, et al.. (2006). Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines. International Journal of Molecular Medicine. 17(5). 945–9. 26 indexed citations
14.
Cheung, Kin F., Kin‐Mang Lau, Wai Shan Wong, et al.. (2005). Frequent promoter hypermethylation of deleted in liver cancer-1 (DLC-1) gene in human leukemias. Cancer Research. 65. 429–430. 1 indexed citations
15.
Chui, Chung, Johnny Tang, Fung Lau, et al.. (2005). Antiproliferation and induction of cell death of Phaffia rhodozyma (Xanthophyllomyces dendrorhous) extract fermented by brewer malt waste on breast cancer cells. International Journal of Molecular Medicine. 16(5). 931–6. 11 indexed citations
16.
Lau, Fung, Chung Chui, Roberto Gambari, et al.. (2005). Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. International Journal of Molecular Medicine. 16(6). 1157–62. 47 indexed citations
17.
Cheung, Filly, Chung Chui, Albert S. C. Chan, et al.. (2005). Inhibition of proteasome activity in Gleditsia sinensis fruit extract-mediated apoptosis on human carcinoma cells. International Journal of Molecular Medicine. 16(5). 925–9. 17 indexed citations
18.
Chui, Chung, Johnny Tang, Fung Lau, et al.. (2004). Gleditsia sinensis fruit extract induced growth inhibition involves basic fibroblast growth factor and nitric oxide. International Journal of Molecular Medicine. 13(1). 169–73. 10 indexed citations
19.
Chow, Larry M. C., Chung Chui, Johnny Tang, et al.. (2003). Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia. Oncology Reports. 10(5). 1601–7. 27 indexed citations
20.
Cheng, Gregory, John E. Curtis, David Tritchler, & Ernest A. McCulloch. (1985). Response to hydrocortisone of blast progenitors in acute myeloblastic leukemia: An aspect of lineage infidelity. Leukemia Research. 9(12). 1547–1557. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026